Dr. Karl-Heinz Buchheit obtained his degree in pharmacy from the Johann-Wolfgang-Goethe University in Frankfurt/M. (Germany) and his Ph.D. in pharmacology in 1984 from the same university. From 1984 until 1999 he worked as research scientist and group leader in preclinical pharmacology for Novartis/Sandoz in Basel (Switzerland). From December 1999 to August 2013, he was Deputy Head of the Department Biological Standardisation, OMCL Network & HealthCare at the EDQM (Council of Europe, Strasbourg, France) and secretary of the Steering Committee of the Biological Standardisation Programme. Since August 2013 he is Head of the same department which is responsible for the activities of the EDQM in the fields of biological standardisation, the OMCL network, blood transfusion, organ-, tissue and cell transplantation, pharmaceutical care, anti-counterfeit measures and consumer health protection.